文献速递前列腺增生与排尿功能障碍

尿急患者存在中枢敏化症状:LURN II 表型研究

Patients With Urinary Urgency Have Central Sensitization Symptoms-A LURN II Phenotyping Study.
PubMed 文献 · J Urol · 2026-02-26

病例组 CSI A 部分中位分 28.0 高于对照 15.0,CSI≥40 者占 21% 对 3.2%(P<.001)。CSI≥40 与尿急病例的比值比为 9.17,且中枢敏化评分越高 OAB 症状与生活质量越差。

要点

  • 约四分之一 OAB 尿急患者 CSI≥40,提示可能存在中枢敏化。
  • CSI≥40 者作为尿急病例的比值比为 9.17(P<.001)。
  • 中枢敏化评分与 OAB 症状严重度及生活质量差相关。

核心结论

  • 伴尿急的 OAB 患者较对照有更多中枢敏化症状,中枢敏化可能参与至少一部分尿急患者(伴或不伴急迫性尿失禁)的病理过程。

研究设计与样本

  • 采用经验证的自评中枢敏化量表(CSI)评估中枢敏化相关症状,CSI≥40 与存在中枢敏化的可能性较高相关。

主要发现

  • 病例组 CSI A 部分评分中位数 28.0,高于对照组的 15.0。
  • 病例组 CSI≥40(可能存在中枢敏化)的比例为 21%,显著高于对照组的 3.2%(P<.001)。
  • 约四分之一 OAB 病例的 CSI≥40,症状符合中枢敏化。
  • CSI≥40 者作为尿急病例的比值比为 9.17(P<.001)。
  • 中枢敏化评分越高,OAB-q 症状严重度(ρ=0.30,P<.001)、LURN SI-29 尿急分量表(ρ=0.25,P<.001)、LURN SI-29 尿失禁分量表(ρ=0.24,P<.001)评分越高,OAB-q 健康相关生活质量越差(ρ=-0.40,P<.001)。

关键数值与推荐

  • CSI≥40 定义为与存在中枢敏化的可能性较高相关。
  • 病例组 CSI≥40 比例为 21%,对照组为 3.2%(P<.001)。
  • CSI≥40 对比 CSI<40 作为尿急病例的比值比为 9.17(P<.001)。

临床怎么用

  • 对 OAB 尿急患者可考虑用 CSI 筛查中枢敏化,CSI≥40 提示可能存在中枢敏化。
  • 中枢敏化评分较高者 OAB 症状更重、生活质量更差,提示这类患者可能需要针对中枢敏化的评估与管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We examined central sensitization in patients with urinary urgency, with or without urgency urinary incontinence. MATERIALS AND METHODS: Adult male and female patients who presented with urinary urgency, with or without urgency incontinence, and seeking treatment for their overactive bladder (OAB) were enrolled in the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) II Study. A control group without urgency or incontinence was also enrolled. Symptoms associated with central sensitization were assessed using the validated self-reported questionnaire Central Sensitization Inventory (CSI). CSI ≥ 40 is associated with a higher likelihood of having central sensitization. RESULTS: Six hundred seventeen cases with urinary urgency and 125 controls without urinary symptoms were included. Cases had higher CSI part A scores compared with controls (median 28.0 vs 15.0). The percentage of participants likely to have central sensitization (CSI ≥40) was significantly higher in cases vs controls (21% vs 3.2%, P < .001). About one-fourth of OAB cases had symptoms consistent with central sensitization with CSI ≥ 40. CSI ≥ 40 was associated with roughly 9 times the odds of being an urgency case compared with CSI < 40 (odds ratio 9.17, P < .001). Higher central sensitization scores correlated with more severe OAB-q Questionnaire (OAB-q symptom severity, ρ = 0.30, P < .001), urgency symptoms (LURN SI-29 subscale, ρ = 0.25, P < .001), incontinence symptoms (LURN SI-29 subscale, ρ = 0.24, P < .001), and worse quality of life (OAB-q health-related quality of life, ρ = -0.40, P < .001). CONCLUSIONS: Patients with OAB with urinary urgency had more central sensitization symptoms compared with controls. Our data suggested that central sensitization may play a role in at least a subset of patients with urinary urgency, with or without urgency urinary incontinence.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Lai HH, Fossa AJ, Bieber B, et al. Patients With Urinary Urgency Have Central Sensitization Symptoms-A LURN II Phenotyping Study. J Urol. 2026. PMID: 41747105. doi:10.1097/JU.0000000000005014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。